Add to favorites

#Product Trends

World''s First Home-use Neurofeedback Device for Managing Autism

Mente itself is closely associated with AAT Founder and Managing Director, neuroscientist Dr Adrian Attard Trevisan, who developed the product after experiencing the challenges a friend faced in managing his son''s condition. The device is set to revolutionise the way parents and health professionals support autistic children.

“This is personal for me,” said Dr Adrian Attard Trevisan. “When I was a student in Brittany I stayed with a family whose son had Asperger''s. I spent time observing him, trying to understand his behaviour. I wasn''t observing him dispassionately, as a scientist conducting an experiment. I was watching him carefully to see where and how I could help the boy and my friend. I knew I had to help. This is when I started to think through how Neurofeedback could be key to allowing my friend''s son, and others like him, focus and better engage with the world around them.” While Mente works on all ages and across a spectrum of autism conditions, AAT prioritises targeting Mente at school-age, autistic children.

Patented Hi-Tech in Action.

In autistic children, the Delta brainwaves, which are naturally elevated at night, remain over-active during the daytime. This causes many of the symptoms and distractions typically associated with autistic people as they struggle to cut through their ‘mental noise''. Mente patented technology listens to the autistic child''s brainwaves to create personalised sounds (binaural beats) designed to stimulate the reduction in the user''s Delta brainwaves.

For over a decade, neurofeedback technology has proved an effective treatment but has until now only been available in some specialised institutions. Mente solves the challenge of making neurofeedback technology available for home use at an affordable price and without the need of specialist supervision.

Read Full Press Release: http://tinyurl.com/pkejngd

Details

  • AAT Medical

    Keywords